Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Odontology ; 112(1): 264-271, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37261608

ABSTRACT

Understanding the relationship between a patient's systemic and oral health is key for clinicians. The aim of this study was to determine if there is an association between specific findings in a dental exam, such as class V carious lesions, and the American Society of Anesthesiologists (ASA) classification as a proxy for systemic health. A retrospective chart review was performed on all patient charts that met inclusion criteria including detailed, complete, and vetted charts obtained over a three-year period in the predoctoral clinic of a United States dental college. Findings recorded at the initial exam included the decayed, missing or filled teeth (DMFT) score, the location of carious lesions and restorations, the presence of periodontal disease, the number of endodontically treated teeth and the number of fractured teeth or restorations. We found no association found between DMFT score and ASA status but did find that ASA I patients had a higher degree of occlusal carious lesions and that ASA III patients were more likely to have interproximal restorations and fractured teeth. We found associations between a greater number of missing teeth and the presence of periodontal disease with worsening ASA status. Our data suggest that ASA classification cannot be used as a reliable predictor for the health of a patient's dentition or the number of cervical caries. However, the data does demonstrate a positive correlation between the number of missing teeth and ASA status, promoting the idea that the number of missing teeth is a crude prognosticator of systemic health. This information can be used by physicians and dentists to help understand the relationships between a patient's dental and systemic health.


Subject(s)
Dental Caries , Periodontal Diseases , Tooth Loss , Humans , Retrospective Studies , Periodontal Diseases/epidemiology , Oral Health , Dental Caries/epidemiology , DMF Index
2.
J Oral Pathol Med ; 51(1): 86-97, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34907617

ABSTRACT

BACKGROUND: Oral lichen planus (OLP) is a chronic inflammatory disorder of the oral mucosa. Currently there is no approved treatment for OLP. We report on the efficacy and safety of a novel mucoadhesive clobetasol patch (Rivelin® -CLO) for the treatment of OLP. METHODS: Patients with confirmed OLP and measurable symptomatic ulcer(s) participated in a randomized, double-blind, placebo-controlled, multicenter clinical trial testing a novel mucoadhesive clobetasol patch (Rivelin® -CLO) in OLP across Europe, Canada, and the United States. Patients were randomized to placebo (nonmedicated), 1, 5, 20 µg Clobetasol/patch, twice daily, for 4 weeks. The primary endpoint was change in total ulcer area compared to baseline. Secondary endpoints included improvement from baseline in pain, disease activity, and quality of life. RESULTS: Data were analyzed and expressed as mean [SD]. One hundred thirty-eight patients were included in the study; 99 females and 39 males, mean age was 61.1 [11.6] years. Statistical analyses revealed that treatment with 20-µg Rivelin® -CLO patches demonstrated significant improvement with ulcer area (p = 0.047), symptom severity (p = 0.001), disease activity (p = 0.022), pain (p = 0.012), and quality of life (p = 0.003) as compared with placebo. Improvement in OLP symptoms from beginning to the end of the study was reported as very much better (best rating) in the 20-µg group (25/32) patients compared to the placebo group (11/30), (p = 0.012). Adverse events were mild/moderate. Candidiasis incidence was low (2%). CONCLUSIONS: Rivelin® -CLO patches were superior to placebo demonstrating statistically significant, clinically relevant efficacy in objective and subjective improvement and, with a favorable safety profile.


Subject(s)
Clobetasol , Lichen Planus, Oral , Administration, Topical , Clobetasol/adverse effects , Female , Glucocorticoids , Humans , Lichen Planus, Oral/drug therapy , Male , Middle Aged , Quality of Life
3.
Am J Case Rep ; 22: e929553, 2021 Mar 19.
Article in English | MEDLINE | ID: mdl-33739960

ABSTRACT

BACKGROUND Parotitis is an inflammation of the parotid gland, which can be caused by factors including infection, radiation, and hyposalivation secondary to systemic conditions, such as Sjögren syndrome, rheumatoid arthritis, or medication. Bacterial parotitis is a rare complication that can be observed in patients with hyposalivation. However, it is also observed in elderly and immunocompromised patients. Lack of continuous flushing of salivary glands and their ducts due to decreased salivary flow renders the glands prone to retrograde colonization with oral microflora. Several microorganisms have been associated with bacterial infections of the parotid glands; Staphylococcus aureus is the most common, accounting for 80% of cases, followed by mixed bacterial communities, including streptococci, anaerobes, and gram-negative bacilli. Bacterial parotitis presents as tenderness, swelling, and purulent sialorrhea from the salivary gland's duct. Immediate administration of broad-spectrum antibiotics, based on the results of the patient's culture and sensitivity test, has shown success in treating these cases. CASE REPORT We report 3 cases of chronic suppurative parotitis secondary to dry mouth and due to Sjögren syndrome that did not respond to oral or intravenous antibiotics and was successfully managed using conservative methods, such as the local application of superficial moist heat and periodic pus drainage by manipulating the parotid glands at dental clinics. CONCLUSIONS We concluded that conservative approaches, such as massaging the glands, local application of superficial moist heat, and periodic pus drainage without using antibiotics, should be considered as the first-line management of bacterial infection of the parotid glands.


Subject(s)
Parotitis , Sjogren's Syndrome , Staphylococcal Infections , Aged , Conservative Treatment , Humans , Parotitis/drug therapy , Parotitis/etiology , Sjogren's Syndrome/complications , Staphylococcal Infections/complications , Staphylococcal Infections/drug therapy , Staphylococcus aureus
5.
Oral Dis ; 27(4): 1052-1058, 2021 May.
Article in English | MEDLINE | ID: mdl-32790928

ABSTRACT

OBJECTIVES: The objective of this retrospective observational study was to determine the incidence of direct-acting oral anti-coagulant (DOA) use in patients receiving invasive dental procedures. The secondary objective was to investigate the precautionary measures implemented and the post/intraoperative complications associated with DOA use. METHODS: Electronic record database, Axium, was retrospectively reviewed, and patients using NGOA and treated between 2010 and 2017 were identified. Charts of patients who underwent invasive dental procedures were further reviewed to investigate the preoperative/intraoperative precautionary measures taken and identify any intraoperative/postoperative complications. RESULTS: A total of 130 patients were identified, with their annual number steadily rising from 12 in 2011 to 52 in 2016. Among those, 64 patients (49.23%) underwent invasive dental procedures. Pretreatment medical consults were obtained in all patients undergoing invasive procedures; however, only 7 (10.94%) were instructed to discontinue their DOA. Preoperative laboratory testing was obtained for two patients. Intraoperatively, 34 (53.13%) cases of excessive bleeding were reported, all were locally controlled with hemostatic agents. Only 4 instances of postoperative complications were documented. CONCLUSIONS: Despite the rise in the use of DOA, there is no consistent pattern for preoperative laboratory testing and DOA discontinuations. Expert consensus may be of great importance to develop practice guidelines.


Subject(s)
Anticoagulants , Postoperative Hemorrhage , Anticoagulants/adverse effects , Humans , Postoperative Hemorrhage/chemically induced , Postoperative Hemorrhage/epidemiology , Postoperative Hemorrhage/prevention & control , Retrospective Studies
6.
Dermatol Clin ; 38(4): 535-541, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32892861

ABSTRACT

Oral mucosal diseases represent a significant health care burden, rendering a complex patient population in which interdisciplinary care among dermatologists, primary dental providers, and dental specialists is required for optimal care. Oral mucosal diseases often cause painful ulceration and blistering which can impede a patient's ability to perform dental home care and the dental professional's ability to deliver routine and complex treatment. It is crucial to consider the environment of the oral cavity. It is paramount to be aware of the potential side effects that certain medications may cause and the possible interactions with other medications the patient is using.


Subject(s)
Dental Care , Dentist's Role , Mouth Diseases/complications , Mouth Diseases/drug therapy , Mouth Mucosa , Tooth Diseases/prevention & control , Drug Interactions , Drug-Related Side Effects and Adverse Reactions/diagnosis , Drug-Related Side Effects and Adverse Reactions/etiology , Early Detection of Cancer , Humans , Mouth Neoplasms/diagnosis , Mouth Neoplasms/pathology , Mouth Neoplasms/prevention & control , Oral Hygiene , Patient Care Team , Self Care
7.
Article in English | MEDLINE | ID: mdl-31078501

ABSTRACT

OBJECTIVES: The Beers criteria and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (STOPP) are consensus-driven lists of potentially inappropriate medications (PIMs) in geriatric patients. The primary objective was to determine the frequency of PIMs prescribed to geriatric patients at Tufts University School of Dental Medicine. The secondary aim was to determine the American Society of Anesthesiologists (ASA) status of these patients and suggest that Beers/STOPP guidelines should be implied with consideration to the patient's ASA status. STUDY DESIGN: Beers/STOPP criteria were studied and PIMs thus identified. A retrospective electronic chart review of patients at TUSDM aged 65 and older was performed for calendar years 2013, 2014, and 2015. Search queries were generated for ASA status, along with PIMs prescribed. RESULTS: Out of 15,569 geriatric patients, more than half of patients between 65-74 years were classified as ASA I. Over a 3-year period, 895 (5.75%) and 840 (5.4%) received new prescriptions for opioids or nonsteroidal anti-inflammatory drugs, respectively. New prescriptions for muscle relaxants, benzodiazepines, and tricyclic antidepressants were given to 65 (0.42%), 44 (0.28%), and 38 (0.24%) patients, respectively. CONCLUSIONS: PIMs are prescribed at low percentages to geriatric patients. However, prescription of opioids, benzodiazepines, and nonsteroidal anti-inflammatory drugs across undergraduate and postgraduate clinics is not uncommon. The majority of Tufts University School of Dental Medicine geriatric patients fall within the category of ASA I-II. ASA classification must be taken into consideration when PIMs are prescribed to geriatric patients rather than relying solely on chronologic age.


Subject(s)
Inappropriate Prescribing , Potentially Inappropriate Medication List , Aged , Aged, 80 and over , Humans , Retrospective Studies
8.
EPMA J ; 10(1): 1-11, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30984309

ABSTRACT

Burning symptoms in the oral cavity are caused by a range of systemic and local factors, in addition to the neuropathic pain disorder burning mouth syndrome (BMS). Patients may state oral burning as a standalone symptom or may report as a secondary symptom in association with other factors, most commonly with oral dryness, oral mucosal lesions, or certain systemic conditions. There is a level of uncertainty in the presentation of this condition which creates a diagnostic challenge from both the patient's perspective and the practitioner evaluating these individuals. The diagnoses are complicated due to the lack of a clear definition of BMS and clinical guidelines to distinguish BMS from other conditions that are responsible for oral burning symptoms. A clinician should be able to differentiate oral burning from burning mouth syndrome. This integrative review discusses on local and systemic etiologies of oral burning based on current evidence that needs to be excluded for a diagnosis of BMS. It also provides an algorithm for diagnostic workup and therapeutic management to medical providers for patients experiencing oral burning symptoms. This comprehensive system provides a systematic stepwise workup in diagnosing and managing patients presenting with a complaint of oral burning that optimally meets a predictive, preventive, and personalized medicine (PPPM) approach.

12.
Article in English | MEDLINE | ID: mdl-27432151

ABSTRACT

OBJECTIVE: The purpose of this study was to determine the accuracy of information provided on websites of dental practices about the diagnosis and management temporomandibular disorders (TMDs) because patients often use the Internet to get information about their condition and to seek a practitioner for treatment. STUDY DESIGN: A web search was done to identify the types of dental providers who advertise themselves on the Internet as "specialists" in the management of TMDs. Issues that were analyzed included their classification of these disorders, the presumed etiology of such problems, and the types of treatment offered. RESULTS: Over two-thirds of the 255 dental providers identified who advertised management of TMDs on their websites were general dentists. TMDs were attributed to occlusal problems or malocclusion on 66.7% of the websites and were labeled as a single disorder rather than a group of disorders on 38.8% of the websites. Recommendations to treat occlusal problems or malocclusion to alleviate TMDs were made by 54.5% of the providers. CONCLUSIONS: Since these findings are not in line with current concepts about TMDs, significant inaccuracies exist with regard to the diagnosis and management of TMDs on dental practice websites. Therefore, patients need to be concerned about the dentists they may select to get their treatment, and practitioners need to be prepared to deal with the issues raised by misinformed patients.


Subject(s)
Dentists , Internet , Patient Education as Topic/standards , Temporomandibular Joint Disorders/diagnosis , Temporomandibular Joint Disorders/therapy , Humans
15.
J Am Dent Assoc ; 146(3): 145-6, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25726338
16.
Article in English | MEDLINE | ID: mdl-25660829

ABSTRACT

Head and neck neoplasms may be difficult to detect because of wide-ranging symptoms and the presence of overlapping anatomic structures in the region. This case report describes a patient with chronic otalgia and temporomandibular disorder, who developed sudden-onset neuralgia while receiving transcutaneous electrical nerve stimulation (TENS) therapy. Further diagnostic evaluation revealed a skull base tumor consistent with adenoid cystic carcinoma. To our knowledge, this is the first report of TENS-associated neuralgia leading to a diagnosis of primary intracranial adenoid cystic carcinoma.


Subject(s)
Carcinoma, Adenoid Cystic/diagnosis , Neuralgia/etiology , Skull Base Neoplasms/diagnosis , Temporomandibular Joint Disorders/therapy , Transcutaneous Electric Nerve Stimulation/adverse effects , Aged , Carcinoma, Adenoid Cystic/therapy , Fatal Outcome , Female , Humans , Magnetic Resonance Imaging , Neuralgia/diagnosis , Pain Management , Pain Measurement , Radiography, Panoramic , Skull Base Neoplasms/therapy , Temporomandibular Joint Disorders/diagnostic imaging , Tomography, X-Ray Computed
17.
J Am Dent Assoc ; 145(10): 1052-7, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25270704

ABSTRACT

BACKGROUND: Malignancies in the head and neck region are difficult to diagnose because of their deep location and presence of symptoms mimicking those of temporomandibular disorders or other orofacial pain disorders. CASE DESCRIPTION: A 75-year-old woman reported experiencing right-sided jaw pain, temporal discomfort and paresthesia. She had undergone conservative therapy for temporomandibular joint disorder, which was unsuccessful. A magnetic resonance image of the midface revealed a mass on the base of the tongue along with possible metastatic lesions to the brain. Further investigation of the lesions revealed them to be metastatic melanoma. PRACTICAL IMPLICATIONS: Patients with atypical symptoms of facial pain, including neurological signs, should undergo further investigation with advanced imaging to determine the source of the symptoms, which could include neoplasms.


Subject(s)
Diagnostic Errors , Melanoma/secondary , Temporomandibular Joint Disorders/diagnosis , Tongue Neoplasms/diagnosis , Aged , Brain Neoplasms/diagnosis , Brain Neoplasms/secondary , Earache/diagnosis , Facial Pain/diagnosis , Female , Humans , Magnetic Resonance Imaging/methods , Melanoma/diagnosis , Paresthesia/diagnosis , Positron-Emission Tomography/methods , Temporal Lobe/pathology
19.
Article in English | MEDLINE | ID: mdl-21749875

ABSTRACT

Morgellons disease is a psycho-dermatologic condition in which patients report fibers or filaments "growing" out of their skin. This case report highlights an oral ulceration in a young woman associated with Morgellons disease, a condition that has not been previously described in the dental literature. An increasing number of individuals are self-reporting this condition and oral health care providers must be familiar with this disorder.


Subject(s)
Gingival Diseases/diagnosis , Morgellons Disease/diagnosis , Oral Ulcer/diagnosis , Adult , Female , Gingival Hemorrhage/diagnosis , Humans , Pruritus/diagnosis , Self-Injurious Behavior/diagnosis , Taste Disorders/diagnosis
20.
Chem Biol Drug Des ; 76(5): 412-24, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20925693

ABSTRACT

The resurgence of tuberculosis and the emergence of multidrug-resistant strains of Mycobacteria necessitate the search for new classes of antimycobacterial agents. We have synthesized a small library of 50 analogues of 4-(arylamino)coumarins with various aromatic amines at the C(4) - position of the coumarin scaffold. The compounds were evaluated for antimycobacterial activity against Mycobacterium tuberculosis H(37) Rv with rifampicin as the standard. Of the molecules synthesized, compound 9 was found to be most potent with a minimum inhibitory concentration >6.25 µg/mL for 100% inhibition. In an effort to develop new and more effective molecules in this series, the relationship between structure and activity was investigated by comparative molecular field analysis. Various models were generated using comparative molecular field analysis alone and comparative molecular field analysis plus a hydropathy field (HINT). In all, eight models were generated with atom-fit and field-fit alignment strategies. The comparative molecular field analysis models (Models 3a and 4a) based on field-fit alignment were the best with statistically good correlation coefficients (r²) and cross-validated q². The values of r²(pred) for the validation set were 0.469 and 0.516. Based on the comparative molecular field analysis contours, some insights into the structure-activity relationship of the compounds could be gained.


Subject(s)
Antitubercular Agents/chemistry , Coumarins/chemistry , Antitubercular Agents/chemical synthesis , Antitubercular Agents/pharmacology , Coumarins/chemical synthesis , Coumarins/pharmacology , Models, Molecular , Mycobacterium tuberculosis/drug effects , Quantitative Structure-Activity Relationship , Rifampin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...